Cellular delivery of MRI contrast agents

被引:71
作者
Allen, MJ
MacRenaris, KW
Venkatasubramanian, PN
Meade, TJ
机构
[1] Northwestern Univ, Dept Chem Biochem & Mol & Cell Biol, Evanston, IL 60208 USA
[2] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA
[3] Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA
[4] ENH Res Inst, Ctr Basic MR Res, Evanston, IL 60201 USA
来源
CHEMISTRY & BIOLOGY | 2004年 / 11卷 / 03期
关键词
D O I
10.1016/j.chembiol.2004.03.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Magnetic resonance imaging (MRI) is a powerful tool for acquiring images of opaque living animals with the benefit of tracking events over extended periods of time on the same specimen. Contrast agents are used to enhance regions, tissues, and cells that are magnetically similar but histologically distinct. A principal barrier to the development of MRI contrast agents for investigating biological questions is the delivery of agents across cellular membranes. Here, we describe the synthesis and in vitro testing of Gd(III)-based MRI contrast agents containing varying length polyarginine oligomers capable of permeating cell membranes. We examine the effect of the length of oligomer on T-1 enhancement and cellular uptake. Furthermore, the effect of incubation time, concentration, and cell type on uptake is explored. Toxicity and washout studies are performed in addition to MRI phantom studies.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 27 条
[1]  
Albericio F, 2000, SOLID-PHASE SYNTHESIS, P275
[2]   Synthesis and visualization of a membrane-permeable MRI contrast agent [J].
Allen, MJ ;
Meade, TJ .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2003, 8 (07) :746-750
[3]  
[Anonymous], 2001, ACOUSTIC CHARACTERIZ
[4]   Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide [J].
Bhorade, R ;
Weissleder, R ;
Nakakoshi, T ;
Moore, A ;
Tung, CH .
BIOCONJUGATE CHEMISTRY, 2000, 11 (03) :301-305
[5]   Fundamentals of positron emission tomography and applications in preclinical drug development [J].
Cherry, SR .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (05) :482-491
[6]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1453-1460
[7]   Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes [J].
Cornish, J ;
Callon, KE ;
Lin, CQX ;
Xiao, CL ;
Mulvey, TB ;
Cooper, GJS ;
Reid, IR .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (05) :E779-E783
[8]   Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles [J].
Dodd, CH ;
Hsu, HC ;
Chu, WJ ;
Yang, PG ;
Zhang, HG ;
Mountz, JD ;
Zinn, K ;
Forder, J ;
Josephson, L ;
Weissleder, R ;
Mountz, JM ;
Mountz, JD .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 256 (1-2) :89-105
[9]  
Freshney R. I., 2010, CULTURE ANIMAL CELLS
[10]   Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery [J].
Futaki, S ;
Suzuki, T ;
Ohashi, W ;
Yagami, T ;
Tanaka, S ;
Ueda, K ;
Sugiura, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) :5836-5840